<p>A gel preparation containing denatured HPMC together with 5-methyl-1-phenyl-2-(1H)-pyridone or a pharmaceutically acceptable salt or ester thereof as the active ingredient. Thus, a gel preparation for treating fibrous skin diseases which is excellent in stable shape retention, spread properties and skin migration of a drug is provided.</p>
